Steelhead Partners LLC Precigen, Inc. Transaction History

Steelhead Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$1.15 - $2.53 $57,499 - $126,499	-50,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $95,500 - $199,000	50,000 New	50,000 $106,000
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $41,000 - $63,882	-11,615 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$6.24 - $8.22 $143,276 - $188,739	-22,961 Reduced 66.41%	11,615 $76,000
Q1 2021 May 12, 2021	BUY	$6.74 - $10.95 $233,042 - $378,607	34,576 New	34,576 $238,000

140

145M

292K

53.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $171M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Steelhead Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Steelhead Partners LLC with notifications on news.